“which requires a successful FDA inspection of the facility handling the manufacturing of our product, including Lonza’s manufacturing facilities”
I would have thought if the FDA had gone through and inspected Lonza’s manufacturing facility, if they had problems they would be told to rectify them, especially any major problems on inspection would of caused a quick disapproval, instead there has been 6 months worth of product being made for gvhd on approval.
“which requires a successful FDA inspection of the facility...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 97.0¢ | $2.821M | 2.832M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20688 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 35000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |